Management of Low Density Lipoprotein Cholesterol at a primary care diabetes clinic in Kuwait

Affiliations


Abstract

Aims: To evaluate the impact of clinical audit and focused interventions on reducing cardiovascular diseases risk by treating Low Density Lipoprotein Cholesterol (LDL-C) in patients with type 2 diabetes attending a primary care clinic in Kuwait.

Methods: Using LDL as a surrogate for cardiovascular risk, the audit team performed a clinical audit with focus on the care process indicator of statin prescription. The basic audit reviewed 100 patients' medical records retrospectively to assess patients' lipid profiles and statin prescription. A lipid management protocol and algorithm based on national clinical practice guidelines distributed to all healthcare professionals and was implemented for 3 months followed by re-audit of another 100 records. Descriptive and comparative statistics (pre and post) were performed using SPSS, version 22.

Results: Statin prescription increased significantly from (26%) in the basic audit to (85%) in the post-intervention audit (p<0.001). The mean LDL-C value decreased significantly from 3.37±0.67mmol/L to 2.71±0.79mmol/L, p<0.001. Mean total cholesterol was significantly reduced from 5.15±0.73mmol/L to 4.68±0.88mmol/L, p<0.001. Ten years CHD risk decreased from 18.46±11.1% to 16.8±12.23%, p=0.152.

Conclusions: Implementing a clinical audit coupled with focused intervention was successful in improving management of LDL-C among patients with type 2 diabetes mellitus attending the primary healthcare sector in Kuwait.

Keywords: Audit; Clinical guidelines; Diabetes; Kuwait; Low Density Lipoprotein Cholesterol.


Similar articles

Cholesterol lowering therapies and achievement of targets for primary and secondary cardiovascular prevention in type 2 diabetes: unmet needs in a large population of outpatients at specialist clinics.

Morieri ML, Avogaro A, Fadini GP; the DARWIN-T2D Network of the Italian Diabetes Society.Cardiovasc Diabetol. 2020 Nov 10;19(1):190. doi: 10.1186/s12933-020-01164-8.PMID: 33172454 Free PMC article.

Utilization of lipid-modifying therapy and low-density lipoprotein cholesterol goal attainment in patients at high and very-high cardiovascular risk: Real-world evidence from Germany.

März W, Dippel FW, Theobald K, Gorcyca K, Iorga ŞR, Ansell D.Atherosclerosis. 2018 Jan;268:99-107. doi: 10.1016/j.atherosclerosis.2017.11.020. Epub 2017 Nov 20.PMID: 29197254

Statin utilization and lipid goal attainment in high or very-high cardiovascular risk patients: Insights from Italian general practice.

Arca M, Ansell D, Averna M, Fanelli F, Gorcyca K, Iorga ŞR, Maggioni AP, Paizis G, Tomic R, Catapano AL.Atherosclerosis. 2018 Apr;271:120-127. doi: 10.1016/j.atherosclerosis.2018.02.024. Epub 2018 Feb 17.PMID: 29499359

Statins: Then and Now.

Toth PP, Banach M.Methodist Debakey Cardiovasc J. 2019 Jan-Mar;15(1):23-31. doi: 10.14797/mdcj-15-1-23.PMID: 31049146 Free PMC article. Review.

Statin Toxicity.

Ward NC, Watts GF, Eckel RH.Circ Res. 2019 Jan 18;124(2):328-350. doi: 10.1161/CIRCRESAHA.118.312782.PMID: 30653440 Review.


KMEL References